Clearance Summary
ePlex Blood Culture Identification Panel - Gram Positive (BCID-GP) Panel received FDA 510(k) clearance under submission number K181663, sponsored by Genmark Diagnostics, Incorporated. The device was reviewed via the Traditional premarket notification pathway and assigned to the Microbiology review panel. The statutory decision date of record is 2018-12-20.
- Submission: K181663
- Applicant / Sponsor: Genmark Diagnostics, Incorporated
- Clearance pathway: Traditional
- Review panel: Microbiology
- Device class: Class II
- Regulation citation: 21 CFR 866.3365
- Decision date: 2018-12-20
Classification & Regulation
This clearance is catalogued under FDA product code PAM and 21 CFR 866.3365, within the Microbiology review panel as a Class II device.